You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Moderate to Severe Plaque PsO

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Plaque Psoriasis Trial (apremilast, Placebo)

Not yet recruiting
  • Plaque Psoriasis
  • (no location specified)
Nov 3, 2023

Validate Cumulative Life Course Impairment Instrument in Adult

Not yet recruiting
  • Psoriasis
    • (no location specified)
    Jul 17, 2023

    Difficult To Treat Sites On Biological Response In

    Completed
    Has Results
    • Plaque Psoriasis
    • Baghdad, Iraq
      Pfizer
    Sep 27, 2021

    Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis Trial (Placebo, Bimekizumab)

    Not yet recruiting
    • Chronic Plaque Psoriasis
    • Moderate to Severe Chronic Plaque Psoriasis
    • (no location specified)
    Aug 21, 2023

    Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis Trial in Canada, United States (Bimekizumab)

    Completed
    • Chronic Plaque Psoriasis
    • Moderate to Severe Chronic Plaque Psoriasis
    • Phoenix, Arizona
    • +38 more
    Jan 6, 2022

    Healthcare Resource Utilization Among Adult Moderate-To-Severe

    Not yet recruiting
    • Psoriasis
      • Nanjing, Jiangsu, China
        Local Institution
      Sep 16, 2022

      Plaque Psoriasis Trial (JNJ-77242113, JNJ-77242113 Matching Placebo, Deucravacitinib)

      Not yet recruiting
      • Plaque Psoriasis
      • (no location specified)
      Nov 16, 2023

      Plaque Psoriasis Trial (TAK-279, Placebo, Apremilast)

      Not yet recruiting
      • Plaque Psoriasis
      • (no location specified)
      Oct 12, 2023

      Patients Treated With Secukinumab for Moderate to Severe Plaque

      Completed
      • Plaque Psoriasis
      • Bangkok, Thailand
        Novartis Investigative Site
      Dec 6, 2022

      Plaque Psoriasis Trial (TAK-279, Placebo, Apremilast)

      Not yet recruiting
      • Plaque Psoriasis
      • (no location specified)
      Oct 25, 2023

      Moderate-to-Severe Plaque Psoriasis Trial in Shenyang (Jaktinib, Placebo)

      Recruiting
      • Moderate-to-Severe Plaque Psoriasis
      • Shenyang, Liaoning, China
        The First Affiliated Hospital of China Medical University
      Nov 28, 2022

      Moderate to Severe Plaque Psoriasis Trial in Worldwide (bimekizumab)

      Active, not recruiting
      • Moderate to Severe Plaque Psoriasis
      • Indianapolis, Indiana
      • +10 more
      Aug 19, 2022

      Tolerability in Pediatric Patients With Psoriasis

      Not yet recruiting
      • Moderate-to-severe Plaque Psoriasis
      • Secukinumab
      • (no location specified)
      Nov 16, 2023

      Psoriasis Trial in China, Korea, Republic of, Taiwan (BMS-986165, Placebo)

      Completed
      • Psoriasis
      • Beijing, Beijing, China
      • +33 more
      Mar 7, 2022

      Plaque Psoriasis Trial in United States (JNJ-77242113, Placebo)

      Recruiting
      • Plaque Psoriasis
      • Rolling Meadows, Illinois
      • +8 more
      Oct 18, 2023

      Deucravacitinib in Moderate-to-Severe Plaque Psoriasis in

      Recruiting
      • Plaque Psoriasis
      • Selters, Rhineland-Palatinate, Germany
        Dermatologische Spezial- und Schwerpunktpraxis Selters
      Oct 23, 2023

      Psoriasis Trial (SAR441566, Placebo)

      Not yet recruiting
      • Psoriasis
      • (no location specified)
      Oct 4, 2023

      Moderate to Severe Chronic Plaque Psoriasis Trial in Mayfield Heights (Stelara, Bmab1200)

      Recruiting
      • Moderate to Severe Chronic Plaque Psoriasis
      • Stelara
      • Bmab1200
      • Mayfield Heights, Ohio
        Apex Clinical Research Center
      Jul 14, 2022

      Preferences of Japan With Moderate-to-Severe Psoriasis Using

      Completed
      • Psoriasis
        • Morrisville, North Carolina
          Local Institution
        Jun 2, 2022

        Psoriasis Trial (IBI112, IBI112/)

        Not yet recruiting
        • Psoriasis
        • (no location specified)
        Sep 19, 2023

        Psoriasis Trial in Shanghai (HS-10374 tablets 1mg, HS-10374 tablets 5mg, HS-10374-matched tablets)

        Not yet recruiting
        • Psoriasis
        • HS-10374 tablets 1mg
        • +2 more
        • Shanghai, Shanghai, China
          Huashan Hospital of Fudan University
        Oct 8, 2023

        Moderate-to-severe Plaque Psoriasis Patients Response to

        Completed
        • Moderate-to-severe Plaque Psoriasis
          • Jakarta, Indonesia
            Mangga Besar Clinic
          Mar 15, 2023

          Psoriasis Trial in Shanghai (608 Q2W, 608 Q4W, Placebo)

          Not yet recruiting
          • Psoriasis
          • 608 Q2W
          • +2 more
          • Shanghai, Shanghai, China
            Shanghai Huanshan Hospital Fudan University
          Sep 8, 2022

          Plaque Psoriasis, Psoriatic Arthritis Trial in India (Ixekizumab)

          Not yet recruiting
          • Plaque Psoriasis
          • Psoriatic Arthritis
          • Raipur, Chhattisgarh, India
          • +14 more
          May 4, 2023

          Psoriasis Trial in Worldwide (Guselkumab)

          Recruiting
          • Psoriasis
          • Frankfurt, Germany
          • +7 more
          Jan 17, 2023